Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery

J Endocrinol Invest. 2015 Mar;38(3):373-4. doi: 10.1007/s40618-014-0221-3. Epub 2014 Dec 6.

Authors

R Modica¹, A Colao¹, A Faggiano²

Affiliations

¹ Division of Endocrinology, Department of Clinical Medicine and Surgery, Section of Endocrinology, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy.
² Division of Endocrinology, Department of Clinical Medicine and Surgery, Section of Endocrinology, University Federico II of Naples, Via S. Pansini 5, 80131, Naples, Italy. afaggian@unina.it.

PMID: 25480427
DOI: 10.1007/s40618-014-0221-3

No abstract available

Publication types

Case Reports
Letter

MeSH terms

ACTH Syndrome, Ectopic / blood
ACTH Syndrome, Ectopic / drug therapy*
Aged
Cabergoline
Drug Therapy, Combination
Ergolines / therapeutic use*
Female
Humans
Octreotide / therapeutic use*
Treatment Outcome

Substances

Ergolines
Cabergoline
Octreotide